Cancer Home > Follicular Lymphoma and Zevalin

If you have been diagnosed with a type of slow-growing, follicular non-Hodgkin's lymphoma, Zevalin® (ibritumomab) may help slow down the progression of the cancer. This prescription drug is approved only for use in adults age 18 and older.
Zevalin works by binding to a certain protein on the surface of healthy cells and certain cancer cells. As a result, it signals the immune system to attack and destroy the cancer cells. This drug is also linked to a radioactive element that emits radiation and destroys surrounding cancer cells.
(Click Zevalin Uses for a closer look at how this type of follicular lymphoma is treated with this drug. This article also talks about whether the medicine is safe for use in older adults and children.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.